Clinical benefit and tolerability of crenolanib in children with relapsed acute myeloid leukemia harboring treatment resistant FLT3 ITD and variant FLT3 TKD mutations treated on compassionate access Meeting Abstract
| Authors: | Tarlock, K.; Meshinchi, S.; Rubnitz, J. E.; Karol, S. E.; Spitzer, B.; Sabnis, A. J.; Pathan, A.; Messahel, B. |
| Abstract Title: | Clinical benefit and tolerability of crenolanib in children with relapsed acute myeloid leukemia harboring treatment resistant FLT3 ITD and variant FLT3 TKD mutations treated on compassionate access |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607205604025 |
| DOI: | 10.1182/blood-2020-140399 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 23 -- Source: Wos |
